Efficacy of peripheral magnetic stimulation to reduce diabetic neuropathic foot pain

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210902009

Enrollment

Registered

2021-09-02

Start date

2020-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To evaluate efficacy of peripheral magnetic stimulation on diabetic neuropathic foot pain. efficacy peripheral magnetic stimulation diabetic neuropathic pain

Interventions

apply magnetic coil at 5 area i. fore foot ii. lateral ankle iii. medial ankle iv. fibular head v. popliteal area mode : A 20 (continuous pulse, frequency 20-30 Hz ) duration : 1 min per area inte

Experimental Device,Sham Comparator Device

Peripheral magnetic stimulation (PMS),Sham Peripheral magnetic stimulation

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Diabetic patient 2. 18-75 yr 3. HbA1c <10.0% within 90 day 4. patient with Neuropathic foot pain according to Douleur neuropathique 4 questions (DN4) 5. VAS > 4 6. informed consent form

Exclusion criteria

Exclusion criteria: 1. Contraindication to PMS 2. Patients with foot ulcer of peripheral arterial disease 3. Other cause of neuropathic pain 4. A communication disorder 5.Psychological patient 6.Not willing to participate 7. Decreased sensation in feet

Design outcomes

Primary

Measure	Time frame
pain 4 week visual analog scale 0-100	—

Secondary

Measure	Time frame
Foot Function Index at 4 week questionaire	—

Countries

Thailand

Contacts

Public ContactNatchaya Kaewma

Phramongkutklao hospital

Beansprouts.m@gmail.com0844007095

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026